Point of care Testing in Emergency Medical Facilities
Emergency medicine, whether pre-hospital or in-hospital, has the main mission of triaging and disposing patients within constrained timeframes and for increasingly complex pathologies.
To achieve these missions, one-third of patients visiting emergency departments receive a prescription for blood test (BT) to aid confirming or ruling out the various diagnoses suggested by emergency physicians.
Time to results of BT impacts the length of stay and participate to the crowding of emergency departments. Point Of Care Testing (POCT) allows obtaining BT results at the patient’s bedside, available 24/7, and provided that analytical precision meets user needs. Therefore, POCT can be facilitating biological tools that accelerate patient flow management and decision-making, including in pre-hospital emergency ambulances. L’attente des résultats de ces EBM impacte la durée de séjour et la surcharge des urgences.
Given the considerable dynamism of POCT sector on the market, our aim is to support the development as well as the validation of the added value and the health-economic impact of POCT devices in emergency medicine.
The POCER network has been granted (November 2024) by the Call for Projects “Clinical Investigation Networks, Medical Devices, and In Vitro Diagnostic Medical Devices” , funded under the France 2030 Health Innovation Plan and operated by the French National Research Agency (ANR-24-DIME-0003).
This network consists of emergency physicians, medical biologists, and a health economic methodologist, who are local and national experts in the evaluation and implementation of POCT in emergency medicine, notably through national and international publications.
The POCER network provides its expertise for:
for conducting clinical studies/projects
on methodological and regulatory aspects
